REFERENCIAS BIBLIOGRÁFICAS
Arbaiza, D. Neurofisiología del dolor. Bol. Dolor, 14(44):14-40, 2005.[Links]
Arendt-Nielsen, L.; Nie, H.; Laursen, M.; Laursen, B.; Madeleine, P.; Simonsen, O. & Graven-Nielsen, T. Sensitization in patients with painful knee osteoarthritis. Pain, 149(3):573-81, 2010.[Links]
Bannister, K.; Bee, L. & Dickenson, A. Preclinical and early clinical investigations related to monoaminergic pain modulation. Neurotherapeutics, 6(4):703-12, 2009.[Links]
Bannister, K.; Patel, R.; Gonçalves, L.; Townson, L. & Dickenson, A. Diffuse noxious inhibitory controls and nerve injury: Restoring an imbalance between descending monoamine inhibitions and facilitations. Pain, 156(9):1083-11, 2015.[Links]
Bushnell, C.; Ceko, M. & Low, L. Cognitive and emotional control of pain and its disruption in chronic pain. Nat. Rev. Neurosci., 14(7):502-11, 2013.[Links]
Cervero, F. Understanding Pain. Massachusetts. The MIT Press, 2012.[Links]
Chichorro, J.; Porreca, F. & Sessle, B. Mechanisms of craniofacial pain. Cephalalgia, 37(7):613-26, 2017.[Links]
Craig, A. A new view of pain as a homeostatic emotion. Trends Neurosci., 26(6):303-7, 2003.[Links]
Damien, J.; Colloca, L.; Bellei-Rodriguez, C. E. & Marchand S. Pain modulation: from conditioned pain modulation to placebo and nocebo effects in experimental and clinical pain. Int. Rev. Neurobiol., 139:255-96, 2018.[Links]
Edwards, R.; Ness, T.; Weigent, D. & Fillingim, R. Individual differences in diffuse noxious inhibitory controls (DNIC): association with clinical variables. Pain, 106(3):427-37, 2003.[Links]
Kirkpatrick, D.; McEntire, D.; Hambsch, Z.; Kerfeld, M.; Smith, T.; Reisbig, M.; Youngblood, Ch. & Agraval, D. Therapeutic Basis of Clinical Pain Modulation. Clin. Transl. Sci., 8(6):848-56, 2015.[Links]
Lautenbacher, S.; Prager, M. & Rollman, G. B. Pain additivity, diffuse noxious inhibitory controls, and attention: a functional measurement analysis. Somatosens. Mot. Res., 24(4):189-201, 2007.[Links]
Martins, I. & Tavares, I. Reticular formation and pain: The past and the future. Front. Neuroanat., 11:51, 2017.[Links]
Naser, P. V. & Kuner, R. Molecular, cellular and circuit basis of cholinergic modulation of pain. Neuroscience, 387:135-48, 2018.[Links]
Navratilova, E.; Xie, J.; Meske. D.; Qu, C.; Morimura, K.; Okun, A.; Arakawa, N.; Ossipov, M.; Howard, L. & Porreca, F. Endogenous opioid activity in the anterior cingulate cortex is required for relief of pain. J. Neurosci., 35(18):7264-71, 2015.[Links]
Okeson, J. Tratamiento de Oclusión y Afecciones Temporomandibulares. 7a ed. Barcelona, Elsevier, 2013.[Links]
Oono, Y.; Wang, K.; Baad-Hansen, L.; Futarmal, S.; Kohase, H.; Svensson, P. & Arendt-Nielsen, L. Conditioned pain modulation in temporomandibular disorders (TMD) pain patients. Exp. Brain Res., 232(10):3111-9, 2014.[Links]
Ossipov, M. H.; Dussor, G. O. & Porreca, F. Central modulation of pain. J. Clin. Invest., 120(11):3779-87, 2010.[Links]
Pedrajas, J. & Molino, Á. Bases neuromédicas del dolor. Clin. Salud, 19(3):277-93, 2008.[Links]
Perena, M. J.; Perena, M. F.; Rodrigo-Royo, M. & Romera, E. Neuroanatomía del dolor. Rev. Soc. Esp. Dolor, 7(Supl. II):5-10, 2000.[Links]
Porreca, F.; Ossipov, M. & Gebhart, G. Chronic pain and medullary descending facilitation. Trends Neurosci., 25(6):319-25, 2002.[Links]
Roeder, Z.; Chen, Q.; Davis, S.; Carlson, J.; Tupone, D. & Heinricher, N. Parabrachial complex links pain transmission to descending pain modulation. Pain, 157(12):2697-708, 2016.[Links]
Shafiei, I.; Vatankhah, M.; Zarepour, L.; Ezzatpanah, S. & Haghparast, A. Role of D1- and D2-like dopaminergic receptors in the nucleus accumbens in modulation of formalin-induced orofacial pain: Involvement of lateral hypothalamus. Physiol. Behav., 188:25-31, 2018.[Links]
Siahposht-Khachaki, A.; Pourreza, P.; Ezzatpanah, S. & Haghparast, A. Nucleus accumbens dopamine receptors mediate hypothalamus-induced antinociception in the rat formalin test. Eur. J. Pain, 21(7):1285-94, 2017.[Links]
Tobaldini, G.; Sardi, N.; Guilhen, V. & Fischer, L. Pain inhibits ain: an Aascending-descending pain modulation pathway linking mesolimbic and classical descending mechanisms. Mol. Neurobiol., 56(2):1000-13, 2019.[Links]
Villanueva, L. Diffuse noxious inhibitory control (DNIC) as a tool for exploring dysfunction of endogenous pain modulatory systems. Pain, 143(3):161-2, 2009.[Links]
Yarnitsky, D.; Granot, M.; Nahman-Averbuch, H.; Khamaisi, M. & Granovsky, Y. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain, 153(6):1193-8, 2012.[Links]
Zegarra, J. Bases fisiopatológicas del dolor. Acta Med. Peru., 24(2):35-8, 2007.[Links]
